Home
>
US Stocks
>
Oncorus Inc
Oncorus Inc
ONCR

Oncorus Inc (ONCR)

$10.142.78%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
10.4
Today Low/High
9.79 / 10.4
52 Week Low/High
$10.43 / $37.86
Market Cap
$281.7M

Company Details

At Oncorus, the company is focused on driving innovation to deliver next-generation viral immunotherapies to transform outcomes for cancer patients. Oncorus is advancing a portfolio of intratumorally and intravenously administered viral immunotherapies for multiple indications with significant unmet needs based on our oncolytic Herpes Simplex Virus (oHSV) Platform and Synthetic Virus Platform. Designed to deliver next-generation viral immunotherapy impact, our oHSV platform improves upon key characteristics of this therapeutic class to enhance potency without sacrificing safety, including greater capacity to encode transgenes to drive systemic immunostimulatory activity, retention of full replication competency to enable high tumor-killing potency, and orthogonal safety strategies to restrict viral activity to tumor cells. Its lead program, ONCR-177, is designed to be directly administered into a tumor, resulting in high local concentrations of the therapeutic agent, as well as low systemic exposure to the therapy, which we believe could potentially limit systemic toxicities.
Organisation
Oncorus Inc
Employees
56
Industry
Health Technology

Discover more

Frequently Asked Questions

What is Oncorus Inc (ONCR) share price today?

Can Indians buy Oncorus Inc (ONCR) shares?

How can I buy Oncorus Inc (ONCR) shares from India?

Can Fractional shares of Oncorus Inc (ONCR) be purchased?

What are the documents required to start investing in Oncorus Inc (ONCR) stocks?

We are a SEBI registered investement advisor